Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease
- PMID: 29241016
- DOI: 10.1164/rccm.201711-2313LE
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease
Comment on
-
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2017 Aug 15;196(4):438-446. doi: 10.1164/rccm.201703-0449OC. Am J Respir Crit Care Med. 2017. PMID: 28375647 Clinical Trial.
-
Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2018 May 1;197(9):1229-1230. doi: 10.1164/rccm.201710-2092LE. Am J Respir Crit Care Med. 2018. PMID: 29241021 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
